Tanja Schneider
- Microbiology top 0.1%
- Antimicrobial Peptides and Activities 24
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 9
- Infectious Diseases top 2%
- Antimicrobial Resistance in Staphylococcus 22
- Pharmacology top 1%
- Microbial Natural Products and Biosynthesis 28
- Molecular Biology top 2%
- Biochemical and Structural Characterization 30
- RNA and protein synthesis mechanisms 11
-
- Bacterial Genetics and Biotechnology 17
-
- Probiotics and Fermented Foods 8
Tanja Schneider
92 papers receiving 4.6k citations
Peers
Comparison fields: 5 of 132
- Microbiology 1.7k
- Molecular Medicine 648
- Infectious Diseases 950
- Pharmacology 844
- Molecular Biology 2.9k
Countries citing papers authored by Tanja Schneider
This map shows the geographic impact of Tanja Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanja Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanja Schneider more than expected).
Fields of papers citing papers by Tanja Schneider
This network shows the impact of papers produced by Tanja Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanja Schneider. The network helps show where Tanja Schneider may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tanja Schneider, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 11 | |
| 2 | 2023 | 11 | |
| 3 | 2022 | 7 | |
| 4 | 2022 | 2 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 34 | |
| 7 | 2022 | 7 | |
| 8 | 2022 | 4 | |
| 9 | 2021 | 12 | |
| 10 | 2019 | 43 | |
| 11 | 2018 | 10 | |
| 12 | 2016 | 304 | |
| 13 | 2016 | 60 | |
| 14 | 2013 | 98 | |
| 15 | 2012 | 46 | |
| 16 | 2010 | 430 | |
| 17 | Plectasin, a fungal defensin antibiotic peptide, targets the bacterial cell wall precursor Lipid II | 2009 | 1 |
| 18 | 2008 | 75 | |
| 19 | 2003 | 138 | |
| 20 | 1985 | 38 |
About Tanja Schneider
Tanja Schneider is a scholar working on Microbiology, Molecular Medicine and Pharmacology, having authored 98 papers that have together received 4.7k indexed citations. Recurring topics across this work include Biochemical and Structural Characterization (30 papers), Microbial Natural Products and Biosynthesis (28 papers), Antimicrobial Peptides and Activities (24 papers), Antimicrobial Resistance in Staphylococcus (22 papers), Bacterial Genetics and Biotechnology (17 papers), RNA and protein synthesis mechanisms (11 papers), Antibiotic Resistance in Bacteria (9 papers) and Probiotics and Fermented Foods (8 papers). The work is most often cited by research in Microbiology (1.7k citations), Molecular Medicine (648 citations) and Infectious Diseases (950 citations). Tanja Schneider has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Hans‐Georg Sahl, Anna Müller, Imke Wiedemann, Fabian Grein, Arnold S. Bayer, Daniela Münch, V. P. SASS, Alessandro Tossi, Raquel Regina Bonelli and Anna Klöckner. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.